Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Vincentage Pharma Co., Ltd

Clinical trials sponsored by Vincentage Pharma Co., Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill aims to tackle high blood pressure and weight together Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1 Not yet finished but already full! 1 Completed 4

New pill aims to tackle high blood pressure and weight together

Disease control Not yet recruiting

This study tests a new drug called VCT220 in 160 adults with high blood pressure who are also overweight or obese. Participants will take either VCT220 or a placebo pill for 20 weeks. The main goal is to see if VCT220 can safely lower blood pressure more than a placebo.

Phase 2 • Sponsor: Vincentage Pharma Co., Ltd • Aim: Disease control

Last updated Jun 27, 2026 08:12 UTC